Search all trials

Find therapies in clinical trials near you

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Bronchiectasis

Recruiting

Investigational

Study of BI 1291583 tablets taken once daily for 76 weeks in adults with bronchiectasis

Investigational

Germany

Participants:0–17 years · 18–64 years · 65+ years
Substances:Bi 1291583

Contact Research Centre

Idiopathic pulmonary fibrosis

Recruiting

Investigational

Study to evaluate the safety and effectiveness of inhaled nintedanib in patients with idiopathic pulmonary fibrosis

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Nintedanib

Contact Research Centre

Depression

Recruiting

Registered drug

Testing dehydroepiandrosterone combined with standard antidepressants for patients with treatment-resistant depression

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Lactose Monohydrate

Contact Research Centre

Major depression

Recruiting

Investigational

Study of milsaperidone as an additional treatment for adults with Major Depressive Disorder who are already taking antidepressants

Investigational

Germany

Participants:18–64 years
Substances:(1S)-1-[4-[3-[4-(6-FLUORO-1,2-BENZOXAZOL-3-YL)PIPERIDIN-1-YL]PROPOXY]-3-METHOXYPHENYL]ETHANOL

Contact Research Centre

Malignant peritoneal neoplasm+2

Recruiting

Registered drugNo placebo

Comparison of Niraparib alone versus Niraparib with Bevacizumab in patients with newly diagnosed advanced ovarian cancer after chemotherapy with carboplatin and paclitaxel

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Bevacizumab

Contact Research Centre

Breast cancer metastatic

Recruiting

Registered drugNo placebo

Study on Adding Elacestrant to Olaparib for Patients with HR-Positive, HER2-Negative Advanced Breast Cancer with gBRCA1/2 Mutations

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Olaparib

Contact Research Centre

Hormone receptor positive breast cancer+2

Recruiting

Registered drugNo placebo

Study on Ribociclib and Drug Combination for Patients with Advanced HER2-Negative, Hormone Receptor Positive Breast Cancer

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Anastrozole

Contact Research Centre

Study of Camizestrant for Patients with ER+/HER2- Early Breast Cancer After 2 Years of Standard Endocrine Therapy

Recruiting

Registered drugNo placebo

Study of Camizestrant for Patients with ER+/HER2- Early Breast Cancer After 2 Years of Standard Endocrine Therapy

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Anastrozole

Contact Research Centre

Idiopathic pulmonary fibrosis

Not yet recruiting

Registered drugNo placebo

Randomized Phase 3 Study of Deupirfenidone (LYT‑100) versus Pirfenidone in Adults with Idiopathic Pulmonary Fibrosis

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Deupirfenidone

Contact Research Centre

Interstitial lung disease+2

Not yet recruiting

InvestigationalNo placebo

Long‑term Safety and Tolerability of Admilparant in Adults with Idiopathic or Progressive Pulmonary Fibrosis

InvestigationalNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:ADMILPARANT

Contact Research Centre

Pulmonary fibrosis

Not yet recruiting

Investigational

A study to evaluate the effectiveness and safety of admilparant in patients with progressive pulmonary fibrosis

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:ADMILPARANT

Contact Research Centre

Major depression

Not recruiting

Registered drug

Testing Ulotaront Added to Antidepressants for Adults with Major Depressive Disorder Who Did Not Respond Well to Initial Treatment

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Citalopram

Contact Research Centre

Find therapies in clinical trials near you

20 trials match your criteria

Bronchiectasis

Study of BI 1291583 tablets taken once daily for 76 weeks in adults with bronchiectasis

Idiopathic pulmonary fibrosis

Study to evaluate the safety and effectiveness of inhaled nintedanib in patients with idiopathic pulmonary fibrosis

Depression

Testing dehydroepiandrosterone combined with standard antidepressants for patients with treatment-resistant depression

Major depression

Study of milsaperidone as an additional treatment for adults with Major Depressive Disorder who are already taking antidepressants

Malignant peritoneal neoplasm+2

Comparison of Niraparib alone versus Niraparib with Bevacizumab in patients with newly diagnosed advanced ovarian cancer after chemotherapy with carboplatin and paclitaxel

Breast cancer metastatic

Study on Adding Elacestrant to Olaparib for Patients with HR-Positive, HER2-Negative Advanced Breast Cancer with gBRCA1/2 Mutations

Hormone receptor positive breast cancer+2

Study on Ribociclib and Drug Combination for Patients with Advanced HER2-Negative, Hormone Receptor Positive Breast Cancer

Study of Camizestrant for Patients with ER+/HER2- Early Breast Cancer After 2 Years of Standard Endocrine Therapy

Study of Camizestrant for Patients with ER+/HER2- Early Breast Cancer After 2 Years of Standard Endocrine Therapy

Idiopathic pulmonary fibrosis

Randomized Phase 3 Study of Deupirfenidone (LYT‑100) versus Pirfenidone in Adults with Idiopathic Pulmonary Fibrosis

Interstitial lung disease+2

Long‑term Safety and Tolerability of Admilparant in Adults with Idiopathic or Progressive Pulmonary Fibrosis

Pulmonary fibrosis

A study to evaluate the effectiveness and safety of admilparant in patients with progressive pulmonary fibrosis

Major depression

Testing Ulotaront Added to Antidepressants for Adults with Major Depressive Disorder Who Did Not Respond Well to Initial Treatment

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.